VALUE IN HEALTH
Scope & Guideline
Innovative Research Shaping Tomorrow's Health Policies
Introduction
Aims and Scopes
- Health Economic Evaluations:
The journal includes studies that assess the cost-effectiveness, budget impact, and value of health interventions, providing insights into economic implications for healthcare systems. - Patient-Reported Outcomes:
Papers often explore patient-reported outcomes (PROs) and quality of life measures, highlighting the importance of patient perspectives in evaluating health interventions. - Real-World Evidence (RWE):
A significant focus is on real-world data and its application in health technology assessments, offering insights into treatment patterns and outcomes outside of clinical trials. - Health Policy and Decision-Making:
The journal addresses health policy implications, including how economic evaluations can guide reimbursement decisions and access to innovative therapies. - Comparative Effectiveness Research:
VALUE IN HEALTH publishes studies comparing the effectiveness of different health technologies and treatments, aiding stakeholders in making informed choices. - Methodological Advances:
The journal encourages methodological innovations in health economics, including statistical modeling techniques and frameworks for health technology assessment.
Trending and Emerging
- Integration of Artificial Intelligence (AI) in Health Economics:
There is a growing trend of utilizing AI and machine learning techniques to enhance economic modeling, improve predictive analytics, and streamline the research process in health economics. - Focus on Equity in Healthcare:
Emerging research emphasizes health equity, exploring disparities in access to healthcare and treatment outcomes, particularly in marginalized communities. - Patient Engagement and Experience:
A rising number of studies are addressing patient engagement in health technology assessments, emphasizing the importance of incorporating patient preferences and experiences. - Digital Health Interventions:
The journal is increasingly publishing research on the economic evaluation of digital health technologies, reflecting the rapid advancement and adoption of telehealth and mobile health solutions. - Long COVID and its Economic Impact:
With the ongoing effects of the COVID-19 pandemic, there is an emerging focus on the long-term economic and health impacts of long COVID, including healthcare utilization and patient outcomes. - Value-Based Care Models:
The shift towards value-based care is reflected in the growing number of publications analyzing the cost-effectiveness and outcomes of value-based treatment approaches.
Declining or Waning
- Traditional Cost-Effectiveness Analysis:
There is a noticeable decline in studies focusing solely on traditional cost-effectiveness analysis without incorporating broader value frameworks or real-world applications. - Pharmaceutical Pricing Strategies:
Research centered on pharmaceutical pricing strategies has decreased, potentially due to increased scrutiny and regulatory changes surrounding drug pricing in various countries. - Single-Arm Trials in Economic Evaluations:
The use of single-arm trials for economic evaluations has become less frequent as the preference shifts towards more robust comparative effectiveness studies that utilize real-world data. - Basic Health Technology Assessments:
Basic assessments without a comprehensive value perspective are declining, as stakeholders increasingly seek integrated approaches that consider multiple dimensions of value.
Similar Journals
Farmeconomia-Health Economics and Therapeutic Pathways
Exploring the economic dimensions of health policy and practice.Farmeconomia-Health Economics and Therapeutic Pathways is a pioneering journal within the field of health economics, dedicated to exploring the intersections of health policy, therapeutics, and economic evaluations. Published by SEED MEDICAL PUBLISHERS, this Open Access journal has been at the forefront of advancing knowledge since 2012, ensuring that vital research is readily accessible to a global audience without subscription barriers. The journal aims to facilitate the dissemination of insightful studies, systematic reviews, and theoretical discussions that determine the cost-effectiveness of therapeutic options, ultimately guiding evidence-based healthcare decisions. Based in *Torino, Italy*, this journal is committed to serving researchers, healthcare professionals, and students who are eager to contribute to and stay updated on the latest developments in health economics and policy implementation. With its broad-ranging scope and dedication to quality research, Farmeconomia stands as an essential resource for anyone engaged in the complex dynamics of health systems and their economic implications.
Gesundheitsoekonomie und Qualitaetsmanagement
Transforming Healthcare through Economic Understanding and Quality FocusGesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.
Journal of the National Comprehensive Cancer Network
Elevating Cancer Care: Insights and Innovations for TomorrowThe Journal of the National Comprehensive Cancer Network (ISSN: 1540-1405, E-ISSN: 1540-1413) is a premier publication in the field of oncology, established by HARBORSIDE PRESS and running since 2003. This highly respected journal holds a remarkable Q1 ranking in both Medicine (Miscellaneous) and Oncology categories, showcasing its significant influence and contribution to cancer research, with a Scopus ranking placing it within the top 5% of its field (Rank #20 out of 404). Aimed at a diverse audience including researchers, clinicians, and students, the journal publishes a wide range of articles that explore cutting-edge findings, clinical practices, and evidence-based guidelines in cancer care. With its commitment to advancing the understanding and treatment of cancer, it serves as a vital resource for professionals dedicated to improving patient outcomes. Although it does not currently offer open access, its impactful content continues to be a cornerstone for anyone involved in oncology research and practice.
MEDICAL DECISION MAKING
Leading the way in health policy insights since 1981.Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.
Cost Effectiveness and Resource Allocation
Empowering Decisions for Effective Resource AllocationCost Effectiveness and Resource Allocation is a premier open-access journal published by BMC, dedicated to advancing the field of health policy and economics. Since its inception in 2003, the journal has provided a platform for researchers, policymakers, and healthcare professionals to disseminate crucial findings and insights relevant to cost-effectiveness analyses and resource allocation strategies. With an increasing impact factor and ranking within the Q2 category of health policy journals, it ranks #138 out of 310 in Scopus, placing it in the 55th percentile among its peers. The journal aims to facilitate knowledge exchange that can transform health policy and improve healthcare delivery through rigorous research, evaluation, and dialogue. Open access since its establishment, it ensures that critical findings are available to a global audience, thereby enhancing the impact and reach of its published works.
Expert Review of Pharmacoeconomics & Outcomes Research
Shaping the Future of Healthcare with Evidence-Based InsightsExpert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.
Health Economics Review
Advancing insights in health economics and policy.Health Economics Review is a premier, peer-reviewed journal dedicated to advancing knowledge and research in the dynamic field of health economics and policy. Published by BMC, this Open Access journal has been a vital resource since 2011, providing a platform for scholars and practitioners to share their findings and insights on pressing health policy issues. With an impressive Q2 ranking in the Health Policy category and a Scopus rank of 113 out of 310, it reflects a solid standing within the academic community, capturing a 63rd percentile ranking that underscores its contribution to the field. The journal covers an extensive range of topics including health systems, economic evaluations, and policy analysis, making it essential reading for researchers, health professionals, and policymakers. Located in Germany, with an operational address at CAMPUS, 4 Crinan St, London, the journal is committed to fostering innovation and collaboration in health economics, thereby shaping a healthier future for all.
HEALTH TECHNOLOGY ASSESSMENT
Transforming health policy with innovative technology insights.HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.
Health and Quality of Life Outcomes
Unlocking the Path to Healthier CommunitiesHealth and Quality of Life Outcomes is a premier open-access journal published by BMC, dedicated to advancing the fields of public health and medical research. Since its inception in 2003, this journal has become a vital resource for researchers and practitioners alike, focusing on the multifaceted aspects of health and well-being. It boasts a commendable impact and recognition within its field, holding a prestigious Q1 ranking in both the Medicine (miscellaneous) and Public Health, Environmental, and Occupational Health categories as of 2023. With a Scopus rank of 87/665, placing it in the 86th percentile, the journal showcases high-quality research that contributes to the wider discourse on health quality and health outcomes. As an open-access journal, it ensures unrestricted access to its findings, promoting widespread dissemination of knowledge and facilitating collaboration among scholars, health professionals, and policymakers globally. Its continual publication through 2024 promises to deepen understanding and foster innovations that enhance the quality of life.
JOURNAL OF HEALTH ECONOMICS
Connecting Research and Policy for Enhanced Health OutcomesJOURNAL OF HEALTH ECONOMICS, published by Elsevier, is a leading peer-reviewed journal in the fields of health policy and public health, with an impressive impact factor indicative of its significance in academic research. Since its inception in 1982, the journal has been a pivotal platform for disseminating impactful research that influences health care policies and economic evaluations, addressing critical topics that drive effective health care delivery and resource allocation. With its current ranking of Q1 in both Health Policy and Public Health, Environmental and Occupational Health, it is recognized among the top journals in these areas, boasting a Scopus rank that places it in the top percentiles of health-related publications. Although it operates under a subscription model, researchers and practitioners benefit from its rich repository of studies and analysis that advance knowledge and practice in health economics. The journal remains committed to fostering interdisciplinary dialogue, making it an invaluable resource for researchers, professionals, and students committed to improving health systems and outcomes.